3-D Matrix specializes in innovative healthcare treatments utilizing self-assembling peptide technology. This advanced peptide technology is designed to improve patient outcomes by providing effective solutions for various medical applications, particularly in the fields of gastroenterology, urology, and otolaryngology. Their flagship products, such as PuraStat, PuraBond, and PuraShield, are developed to address critical medical needs, including hemostasis during endoscopic procedures and management of gastrointestinal bleeding. The company emphasizes the importance of clinical validation, with all products undergoing rigorous testing in both clinical and laboratory settings to ensure safety and efficacy.

The company has established a global network of partners and distributors to facilitate the distribution of its products and provide high-quality support to healthcare providers and patients worldwide. 3-D Matrix is committed to continuous research and development, collaborating with leading healthcare professionals to refine their offerings based on real-world data and clinical studies. Their mission reflects a proactive approach to healthcare innovation, aiming to deliver solutions that meet the evolving needs of medical specialties while enhancing patient care.

France

3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery.

Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. 

Follow us on Twitter @3dm_emea

Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription

3-D Matrix

Company Details